Bank of Nova Scotia grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 43.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 427,751 shares of the biopharmaceutical company’s stock after buying an additional 130,552 shares during the […]
Human Investing LLC reduced its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 25.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,526 shares of the biopharmaceutical company’s stock after selling 1,174 shares during the […]
Paradigm Asset Management Co. LLC trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 24,000 shares of the biopharmaceutical company’s stock after selling 700 shares during the quarter. Paradigm Asset Management Co. LLC’s holdings in Gilead Sciences were worth $1,944,000 […]
Edmond DE Rothschild Holding S.A. cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 223,543 shares of the biopharmaceutical company’s stock after selling 448 shares during the quarter. […]
United Services Automobile Association lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 67.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 222,985 shares of the biopharmaceutical company’s stock after acquiring an additional 90,194 shares during the […]